Isotretinoin (Absorica Ld, Clarus) shortage status
No current shortage
Source: Health Canada shortage reports · Updated Sep 3, 2026
Also sold as: Absorica Ld, Clarus, Accutane Roche
Isotretinoin has no current shortage reported in Canada. It has been in shortage before; the history is below.
A retinoid used to treat severe acne.
Products affected
0 / 8
Reports on file
36
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
CLARUS
10MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02257955 · ended Aug 20, 2026 · Demand increase for the drug.
Resolved
CLARUS
40MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02257963 · ended Aug 17, 2026 · Demand increase for the drug.
Resolved
CLARUS
40MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02257963 · ended Mar 17, 2026 · Disruption of the manufacture of the drug.
Resolved
ABSORICA LD
8MG · CAPSULE · SUN PHARMACEUTICAL INDUSTRIES LIMITED
DIN 02539047 · ended Sep 5, 2025 · Disruption of the manufacture of the drug.
Resolved
ABSORICA LD
16MG · CAPSULE · SUN PHARMACEUTICAL INDUSTRIES LIMITED
DIN 02539055 · ended Sep 5, 2025 · Disruption of the manufacture of the drug.
Resolved
ABSORICA LD
16MG · CAPSULE · SUN PHARMACEUTICAL INDUSTRIES LIMITED
DIN 02539055 · ended Jul 10, 2025 · Delay in shipping of the drug.
Resolved
ACCUTANE ROCHE
40MG · CAPSULE · HOFFMANN-LA ROCHE LIMITED
DIN 00582352 · ended Apr 1, 2025 · Disruption of the manufacture of the drug.
Resolved
ACCUTANE ROCHE
10MG · CAPSULE · HOFFMANN-LA ROCHE LIMITED
DIN 00582344 · ended Apr 1, 2025 · Disruption of the manufacture of the drug.
Resolved
CLARUS
10MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02257955 · ended Mar 25, 2025 · Disruption of the manufacture of the drug.
Resolved
CLARUS
40MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02257963 · ended Mar 13, 2025 · Disruption of the manufacture of the drug.
Resolved
ABSORICA LD
16MG · CAPSULE · SUN PHARMACEUTICAL INDUSTRIES LIMITED
DIN 02539055 · ended Mar 5, 2025 · Delay in shipping of the drug.
Resolved
CLARUS
10MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02257955 · ended Jan 6, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 36 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Isotretinoin. Health Canada has 36 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Isotretinoin is classified under “ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE” (ATC D10BA).
Recent changes
Sep 3, 2026
Shortage resolved
Aug 25, 2026
Shortage resolved
Aug 10, 2026
Estimated end date moved earlier : Aug 18, 2026 → Aug 17, 2026
Aug 10, 2026
Estimated end date moved earlier : Aug 25, 2026 → Aug 17, 2026
Aug 5, 2026
Estimated end date moved earlier : Sep 1, 2026 → Aug 18, 2026
Aug 5, 2026
Estimated end date moved earlier : Sep 1, 2026 → Aug 25, 2026
Jul 13, 2026
Estimated end date pushed back : Aug 18, 2026 → Sep 1, 2026
Jul 13, 2026
Estimated end date pushed back : Aug 18, 2026 → Sep 1, 2026
Common questions
What is Isotretinoin used for?
A retinoid used to treat severe acne.
When will Isotretinoin be back in stock in Canada?
Isotretinoin has no active shortage; supply is normal per Health Canada reports.
Why is Isotretinoin in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.